Persons with mild-to-moderate asthma should not apply inhaled steroids daily

Inhaled corticosteroids are medicines that are applied in case of asthma by children and adults. Individuals that experience mild, moderate and severe asthma utilize these preparations daily. These medicines prevent inflammation of the airways. Health care providers supervise persons with this disease, adjusting dosage schedule every 6 weeks.
Unfortunately, inhaled steroids, like other preparations, may lead to unwanted effects. Regular application of these medicines is associated with several risks. Is there any method for individuals with asthma to prevent these problems?
A recent study has displayed that physicians should not recommend using these medications daily to persons with mild-to-moderate asthma. This research turned out to be very valuable. It is likely to alter indications related to treatment of asthma.
The study was conducted by doctors of the Texas Medical Brach in Galveston. Dr. William Calhoun and his colleagues enrolled 340 persons with asthma in the research. Certain persons were given inhaled corticosteroids daily; others administered these medicines, when symptoms of asthma attacks appeared. Bronchial reactivity and functions of lungs were measured by the specialists during nine months. The results of the research demonstrated that there was not any significant difference between these two groups.
According to the specialists, if inhaled corticosteroids are taken, when symptoms appear, exacerbation can be prevented. Moreover, these preparations have long action. It means that benefits are felt even several days after usage. The scientists suppose that these preparations may be administered by individuals with mild-to-moderate asthma only when symptoms appear.
Why is this research valuable? According to certain sources, 25 million Americans experience asthma. Of course, they must be treated. This piece of news must be valuable for them. Moreover, if inhaled steroids are used prolonged time, they may lead to grave negative reactions, such as hormonal imbalance, cataract, etc. So, if individuals that experience mild-to-moderate asthma don’t apply these drugs each day, they are more unlikely to get these negative results.
Undoubtedly, it is early to modify indications linked with treatment of asthma. But this research may induce conducting further researches that may lead to certain changes.